Global Health Innovative Technology (GHIT) Fund Revenue

Non-profit Organizations • Minato-Ku, Tokyo, Japan • 21-50 Employees

Global Health Innovative Technology (GHIT) Fund revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$385,000
Estimated valuation?This valuation is estimated based on industry average for the Non-profit Organizations industry and current estimated revenues	$32,000,000
Total funding	No funding

Key Contacts at Global Health Innovative Technology (GHIT) Fund

Rajeev Venkayya

Member Board Of Directors

Kiichiro Kobori

Associate Director

Osamu Kunii

Chief Executive Officer Ceo ; Executive Director

Isaac Chikwanha

Senior Director

Miho Takazawa

Senior Director, Finance & Opera

Eriko Mugitani

Director

Company overview

Headquarters	Ark Hills Sengokuyama Mori Tower 25F, 1-9-10 Roppongi, Minato-ku, Tokyo, 106-0032, JP
Website	ghitfund.org
NAICS	813
SIC	839
Keywords	Screening, Drugs, HIV, Leadership, Investment, R&D, Malaria, Vaccines, Grantmaking, TB, Discovery And Development, Global Health Research And Development, Japanese Innovation, Ntds
Founded	2013
Employees	21-50
Socials

Global Health Innovative Technology (GHIT) Fund Email Formats

Global Health Innovative Technology (GHIT) Fund uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@ghitfund.org), used 61.1% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@ghitfund.org	61.1%
{first name}.{last name}	john.doe@ghitfund.org	38.9%

About Global Health Innovative Technology (GHIT) Fund

The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, and international philanthropic foundations.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

Global Health Innovative Technology (GHIT) Fund has 10 employees across 6 departments.

Departments

Number of employees

Funding Data

Global Health Innovative Technology (GHIT) Fund has never raised funding before.

Frequently asked questions

Global Health Innovative Technology (GHIT) Fund is located in Minato-Ku, Tokyo, JP.

Global Health Innovative Technology (GHIT) Fund generates an estimated annual revenue of $10,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Global Health Innovative Technology (GHIT) Fund has an estimated valuation of $32,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Global Health Innovative Technology (GHIT) Fund was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Global Health Innovative Technology (GHIT) Fund has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.